» Articles » PMID: 18533196

Evaluation of Microvascular Endothelial Function in Patients with Type 1 Diabetes Using Laser-Doppler Perfusion Monitoring: Which Method to Choose?

Overview
Journal Microvasc Res
Date 2008 Jun 6
PMID 18533196
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The evaluation of microvascular function is essential in the investigation of the pathophysiology of cardiometabolic diseases [Struijker-Boudier, H.A. et al., 2007. Evaluation of the microcirculation in hypertension and cardiovascular disease. Eur. Heart J. 28, 2834-2840]. In clinical research and practice, the study of microcirculation is of great value in the assessment of the effects of medical interventions and monitoring disease progression. It is well-known that patients with type 1 and 2 diabetes have microvascular dysfunction that results from numerous factors including hyperglycemia, oxidative stress and insulin resistance [Schalkwijk, C.G., Stehouwer, C.D., 2005. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin. Sci. (Lond). 109, 143-159]. Moreover, skin microvascular dysfunction in type 1 diabetes precedes symptoms of end-organ microvascular disease [Khan, F. et al., 2000. Impaired skin microvascular function in children, adolescents, and young adults with type 1 diabetes. Diabetes Care 23, 215-220]. In this study, we assessed skin microvascular function of patients with type 1 diabetes using laser-Doppler perfusion monitoring (LDPM) coupled with physiological and pharmacological local vasodilator stimuli.

Citing Articles

Reproducibility and normalization of reactive hyperemia using laser speckle contrast imaging.

Shirazi B, Valentine R, Lang J PLoS One. 2021; 16(1):e0244795.

PMID: 33412561 PMC: 7790538. DOI: 10.1371/journal.pone.0244795.


Systemic microvascular endothelial dysfunction and disease severity in COVID-19 patients: Evaluation by laser Doppler perfusion monitoring and cytokine/chemokine analysis.

Sabioni L, De Lorenzo A, Lamas C, Muccillo F, Castro-Faria-Neto H, Estato V Microvasc Res. 2020; 134:104119.

PMID: 33278457 PMC: 7710468. DOI: 10.1016/j.mvr.2020.104119.


Skin microvascular reactivity correlates to clinical microangiopathy in type 1 diabetes: A pilot study.

Tehrani S, Bergen K, Azizi L, Jorneskog G Diab Vasc Dis Res. 2020; 17(3):1479164120928303.

PMID: 32538145 PMC: 7607411. DOI: 10.1177/1479164120928303.


Early Endothelial Dysfunction in Type 1 Diabetes Is Accompanied by an Impairment of Vascular Smooth Muscle Function: A Meta-Analysis.

Lespagnol E, Dauchet L, Pawlak-Chaouch M, Balestra C, Berthoin S, Feelisch M Front Endocrinol (Lausanne). 2020; 11:203.

PMID: 32362871 PMC: 7180178. DOI: 10.3389/fendo.2020.00203.


Neurovascular microcirculatory vasodilation mediated by C-fibers and Transient receptor potential vanilloid-type-1 channels (TRPV 1) is impaired in type 1 diabetes.

Marche P, Dubois S, Abraham P, Parot-Schinkel E, Gascoin L, Humeau-Heurtier A Sci Rep. 2017; 7:44322.

PMID: 28287157 PMC: 5347083. DOI: 10.1038/srep44322.